Ganglioglioma associated with alterations of NBN gene. A case report

Folia Neuropathologica

Volumn 47, Issue 3, 2009, Pages 278-283

  Grajkowska, Wieslawa ^a   Piekutowska Abramczuk, Dorota ^a   Ciara, Elzbieta ^a   Dembowska Baginska, Bozena ^a   Perek, Danuta ^a   Roszkowski, Marcin ^a   Daskiewicz, Pawel ^a   Matyja, Ewa ^b   Pronicki, Maciej ^a   Chrzanowska, Krystyna H ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

DNA repair genes; Ganglioglioma; NBN gene; Nibrin; Nijmegen breakage syndrome; Paediatric brain tumours

Indexed keywords

CISPLATIN; TEMOZOLOMIDE;

ADOLESCENT; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RADIOTHERAPY; CASE REPORT; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GLIOMA; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE; SEIZURE; TUMOR BIOPSY;

EID: 70350366189     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Becker AJ, Klein H, Baden T, Aigner L, Normann S, Elger CE, Schramm J, Wiestler OD, Blumcke I. Mutational and expression analysis of the reelin pathway components CDK5 and doublecortin in gangliogliomas. Acta Neuropath 2002; 104: 403-408.
2. Becker AJ, Lobach M, Klein H, Normann S, Nothen MM, von Deimling A, Mizuguchi M, Elger CE, Schramm J, Wiestler OD, Blumcke I. Mutational analysis of TSC1 and TSC2 genes in gangliogliomas. Neuropathol Appl Neurobiol 2001; 27: 105-114.
3. Becker AJ, Wiestler OD, Figarella-Branger D, Blumcke I. Ganglioglioma and gangliocytoma. In: Louis ND, Ohgaki H, Wiestler OD, Cavenee WK (eds.). WHO Classification of Tumours of Central Nervous System. Lyon: IARC 2007: 74-78.
4. Biernat W, Zakrzewski K, Polis L, Liberski PR. Glioneuronal-mesenchymal tumour with malignant transformation. Folia Neuropathologica 2007; 45: 140-143.
5. Czornak K, Chughtai S, Chrzanowska KH. Mystery of DNA repair: the role of the MRN complex and ATM kinase in DNA damage repair. J Appl Genet 2008; 49: 383-396.
6. Chrzanowska KH, Piekutowska-Abramczuk D, Popowska E, Gladkowska-Dura M, Maldyk J, Syczewska M, Krajewska-Walasek M, Goryluk-Kozakiewicz B, Bubala H, Gadomski A, Gaworczyk A, Kazanowska B, Koltan A, Kuzmicz M, Luszawska-Kutrzeba T, Maciejka-Kapuscinska L, Stolarska M, Stefanska K, Sznurkowska K, Wakulinska A, Wieczorek M, Szczepanski T, Kowalczyk J. Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies. Int J Cancer 2006; 118: 1269-1274.
7. Dembowska-Baginska B, Perek D, Brozyna A, Wakulinska A, Olczak-Kowalczyk D, Gladkowska-Dura M, Grajkowska W, Chrzanowska KH. Non-Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS). Pediatr Blood Cancer 2009; 52: 186-190.
8. Gladkowska-Dura M, Dzierzanowska-Fangrat K, Dura WT, van Krieken JH, Chrzanowska KH, van Dongen JJ, Langerak AW. Unique morphological spectrum of lymphomas in Nijmegen breakage syndrome (NBS) patients with high frequency of consecutive lymphoma formation. J Pathol 2008; 216: 337-344.
9. Grajkowska W, Kotulska K, Matyja E, Larysz-Brysz M, Mandera M, Roszkowski M, Domanska-Pakiela D, Lewik-Kowalik J, Józwiak S. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type. Folia Neuropathol 2008; 46: 43-48.
10. Hirose T, Scheithauer BW, Lopes MB, Gerber HA, Altermatt HJ, VandenBerg SR. Ganglioglioma: An ultrastructural and immunohistochemical study. Cancer 1997; 79: 989-1003.
11. Huang J, Grotzer MA, Watanabe T, Hewer T, Pietsch T, Rutkowski S, Ohgaki H. Mutations in the Nijmegen breakage syndrome gene in medulloblastomas. Clin Cancer Res 2008; 14: 4053-4058.
12. Izycka-Swieszewska E, Majewska H, Szurowska E, Mazurkiewicz-Beldzinska M, Drozynska E. Papillary glioneuronal tumour of the precentral gyrus. Folia Neuropathol 2008; 46: 158-163.
13. Kobayashi J, Antoccia A, Tauchi H, Matsuura S, Komatsu K. NBS1 and its functional role in the DNA damage response. DNA Repair 2004; 3: 855-861.
14. Luyken C, Blumcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J. Supratentorial gangliogliomas: histopathologic grading and tumor reccurence in 184 patients with a median follow-up of 8 years. Cancer 2004; 101: 146-155.
15. Meyer P, Eberle MM, Probst A, Tolnay M. Ganglioglioma of optic nerve in neurofibromatosis type 1. Case report and review of the literature. Klin Monatsbl Augenheilkd 2000; 217: 55-58.
16. Mosor M, Ziólkowska I, Pernak-Schwarz M, Januszkiewicz-Lewandowska D, Nowak J. Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia. Leukemia 2006; 20: 1454-1456.
17. Nowak J, Mosor M, Ziólkowska I, Wierzbicka M, Pernak-Schwarz M, Przyborska M, Roznowski K, Plawski A, Slomski R, Januszkiewicz D. Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours. Eur J Cancer 2008; 44: 627-630.
18. Osborne AG. Diagnostic neuroradiology. Mosby, St Louis 1994.
19. Petrini JHJ, Stacker TH. The cellular response to DNA doublestrand breaks: defining the sensors and mediators. Trends Cell Biol 2003; 13: 458-462.
20. Plisiecka-Halasa J, Dansonka-Mieszkowska A, Rembiszewska A, Bidzinski M, Steffen J, Kupryjanczyk J. Nijmegen breakage syndrome gene (NBS1) alterations and its protein (nibrin) expression in human ovarian tumours. Ann Hum Genet 2002; 66: 353-359.
21. Roznowski K, Januszkiewicz-Lewandowska D, Mosor M, Pernak M, Litwiniuk M, Nowak J. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer. Breast Cancer Res Treat 2008; 110: 343-348.
22. Seemanova E, Jarolim P, Seemann P, Varon R, Digweed M, Swift M, Sperling K. Cancer risk of heterozygotes with the NBN founder mutation. J Natl Cancer Inst 2007; 99: 1875-1880.
23. Squire JA, Arab S, Marrano P, Bayani J, Karaskova J, Taylor M, Becker L, Rutka J, Zielenska M. Molecular cytogenetic analysis of glial tumors using spectral karyotyping and comparative genomic hybridization. Mol Diagn 2001; 6: 63-108.
24. Steffen J, Varon R, Mosor M, Maneva G, Maurer M, Stumm M, Nowakowska D, Rubach M, Kosakowska E, Ruka W, Nowecki Z, Rutkowski P, Demkow T, Sadowska M, Bidzinski M, Gawrychowski K, Sperling K. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int J Cancer 2004; 111: 67-71.
25. Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrznowska KH, Saar K, Beckmann G, Seemanova E, Cooper PR, Nowak NJ, Stumm M, Weemaes CM, Gatti RA, Wilson RK, Digweed M, Rosenthal A, Sperling K, Concannon P, Reis A. Nibrin, a nowel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 1998; 93: 467-476.
26. von Deimling A, Fimmers R, Schmidt MC, Bender B, Fassbender F, Nagel J, Jahnke R, Kaskel P, Duerr EM, Koopmann J, Maintz D, Steinbeck S, Wick W, Platten M, Müller DJ, Przkora R, Waha A, Blümcke B, Wellenreuther R, Meyer-Puttlitz B, Schmidt O, Mollenhauer J, Poustka A, Stangl AP, Lenartz D, von Ammon K. Comprehensive allelotype and genetic anaysis of 466 human nervous system tumors. J Neuropathol Exp Neurol 2000; 59: 544-558.
27. Watanabe T, Nobusawa S, Lu S, Huang J, Mittelbronn M, Ohgaki H. Mutational inactivation of the Nijmegen Breakage Syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations. J Neuropathol Exp Neurol 2009; 68: 210-215.
28. Yang M, Chiang W, Chou T, Chang S, Chen P, Teng S, Wu K. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation. Clin Cancer Res 2006; 12: 507-515.
29. Ziólkowska I, Mosor M, Wierzbicka M, Rydzanicz M, Pernak-Schwarz M, Nowak J. Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Cancer Sci 2007; 98: 1701-1705.
30. Zhu XD, Kuster B, Mann M, Petrini JH, de Lange T. Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat Genet 2000; 25: 347-352.